Latest insight from Medicines Law & Policy
WTO Covid-19 TRIPS Decision: Some observations
This morning, 17 June at 5 AM the 12th World Trade Organization (WTO) Ministerial Conference (MC12) approved a package of decisions and declarations. The...
Proposed TRIPS waiver a hollow diplomatic compromise with little practical impact
In October of 2020, 9 months into the pandemic, fearing conflicts over intellectual property (IP) related to medical measures to fight the pandemic, India...
The US NIH will share technology with WHO to fight the pandemic
The US National Institutes of Health today committed to sharing several technologies with a World Health Organization body tasked with increasing access to Covid-19...
With technology transfer, 120 companies in low- and middle-income countries could manufacture mRNA vaccines
Recent reporting from the British Medical Journal (BMJ) has revealed efforts by BioNTech – the technology firm behind Pfizer’s projected $100 billion in Covid-19...
Wrapping up 2021 – some noteworthy medicines law and policy events
Welcome to the annual end of the year blog, our highly biased overview of noteworthy events in the field of medicines law and policy....
Landmark decision by the World Health Assembly to start negotiations for a pandemic treaty
GENEVA, SWITZERLAND: World Health Organization (WHO) member states today decided to pursue an agreement that can better prepare the world to face future pandemics....